Huadong Medicine’s Lanluma V and X Approved for Use in Hainan
China-based Huadong Medicine Co., Ltd (SHE: 000963) has announced receiving approval from the Hainan Medical...
Antengene and MSD Collaborate on Global Clinical Study for ATG-037
China-based Antengene Corporation Limited (HKG: 6996) has announced a global clinical collaboration with Merck, Sharp...
IASO Biotherapeutics Receives FDA Approval for CT103A IND Application
China-based IASO Biotherapeutics has announced approval from the US FDA for an Investigational New Drug...
Shenzhen Würzburg Dynamics Raises RMB 100 Million in Series A Financing Round
China-based Shenzhen Würzburg Dynamics has reportedly raised RMB 100 million (USD 14.36 million) in a...
AcornMed Raises RMB 200 Million in Series B Financing Led by Yikai Venture Capital
AcornMed, a tumor precision medicine specialist based in Beijing, has reportedly raised RMB 200 million...
CSPC’s NBL-020 Receives FDA IND Approval for Advanced Solid Tumors
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced receiving Investigational New Drug (IND) approval...
Jiangsu Chia Tai Tianqing’s TQB2102m Gains NMPA Clinical Approval
Jiangsu Chia Tai Tianqing Pharmaceutical Co., Ltd’s (CTTQ) Category 1 biologic product TQB2102m, an HER2...
WuXi XDC Partners with GeneQuantum for ADC Development
China-based WuXi XDC, a joint venture between Wuxi Biologics (HKG: 2269) and WuXi STA, a...
Hengrui Pharmaceuticals Receives New Approval for Remimazolam Tosylate
China-based Jiangsu Hengrui Pharmaceuticals (SHA: 600276) has announced one new supplementary approval for its gamma-aminobutyric...
Neurophth Partners with Apellis for Gene Therapy Development in AMD
China-based gene therapy specialist Neurophth Biotechnology Ltd has announced a strategic partnership with US firm...
Jing Medicine’s HJM-353 Gains Clinical Trial Approvals in US and China
China-based Jing Medicine Technology (Shanghai) Co., Ltd’s HJM-353 has obtained clinical trial approvals in the...
Jiangsu Vcare PharmaTech Raises RMB 200 Million in Series B Financing Round
China-based Jiangsu Vcare PharmaTech Co. Ltd has reportedly raised over RMB 200 million (USD 28.67...
MindRank AI Receives FDA Approval for MDR-001 Clinical Study in Obesity
Hangzhou-based artificial intelligence (AI)-driven biotech MindRank AI has announced obtaining approval from the US FDA...
Hangzhou Biotest Receives FDA EUA for COVID-19 Antigen Self-Testing Reagent
China-based Hangzhou Biotest Biotech Co., Ltd has announced receiving an Emergency Use Authorization (EUA) from...
Junshi Biosciences Licenses PD-1 Inhibitor Tuoyi to Hikma MENA FZE
China-based Junshi Biosciences (HKG: 1877, SHA: 688180) has announced a licensing agreement with UK-headquartered Hikma...
Shanghai Pharmaceuticals Secures Exclusive Rights for Shionogi’s Ensitrelvir in China
Shanghai Pharmaceuticals (HKG: 2607, SHA: 601607) has announced an import and distribution agreement with Japan-based...
WHO Approves Sinovac’s CoronaVac for Children Aged 3 and Above
The World Health Organization (WHO) has lowered the age limit for Sinovac Biotech Ltd’s (NASDAQ:...
NHSA Orders Investigation into Unreasonable Medical Insurance Restrictions
The National Healthcare Security Administration (NHSA) has released a notification to medical insurance departments across...
Fosun Pharma’s Avatrombopag Receives NMPA Review for Chronic ITP Indication
China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has announced that another...
Nanjing Pharmaceutical to Acquire Majority Stakes in Three Jiangsu Subsidiaries
China-based Shanghai-listed Nanjing Pharmaceutical Co., Ltd (SHA: 600713) is set to acquire a respective 55%,...